MedPath

Phase II study of cord blood transplantation using myeloablative conditioning in adult patiants (C-SHOT 0603)

Phase 2
Conditions
Acute leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome
Registration Number
JPRN-UMIN000000868
Lead Sponsor
Research Grant on Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
28
Inclusion Criteria

Not provided

Exclusion Criteria

1.Active disease in central nerve system. 2.Uncontrollable diabetes 3.Uncontrollable hypertension 4.Active infection 5.Positive for TPHA or HBs antigen 6.Positive for HIV antibody 7.Malignancies addition to primary hematological malignant disease 8.Pregnant or during breast feeding 9.History of stem cell transplantation including autologous transplantation 10.Uncontrollable psycho-neurological symptoms 11.Physician's decision that it is not appropriate to register the patient to this study for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath